ClinConnect ClinConnect Logo
Search / Trial NCT06874660

Effects of Surgical Timing on Perioperative Clinical Outcomes in Pancreaticoduodenectomy

Launched by WEST CHINA HOSPITAL · Mar 9, 2025

Trial Information

Current as of April 30, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients must be required to sign an informed consent form;
  • 2. Age 18-80 years, male and female;
  • 3. ECOG Physical Status Score (PS Score) 0 or 1.
  • 4. Pancreaticoduodenectomy at our center without contraindications related to the surgery.
  • Exclusion Criteria:
  • 1. Pre-existing or concurrent other malignant tumors
  • 2. Severe cardiopulmonary and renal dysfunction.
  • 3. Autoimmune disease or history of immunodeficiency
  • 4. Active infections and infectious diseases requiring systemic therapy.
  • 5. History of psychotropic substance abuse, alcoholism or drug addiction.
  • 6. Failure to meet the inclusion criteria as determined by the investigator.

About West China Hospital

West China Hospital, affiliated with Sichuan University, is a leading medical institution renowned for its comprehensive healthcare services, advanced research initiatives, and commitment to medical education. As a prominent clinical trial sponsor, the hospital leverages its extensive resources and expertise to facilitate innovative research in various therapeutic areas. With a focus on improving patient outcomes and advancing medical knowledge, West China Hospital collaborates with various stakeholders to conduct rigorous clinical trials that adhere to the highest ethical and scientific standards. Its state-of-the-art facilities and multidisciplinary teams ensure the successful execution of trials, contributing significantly to the global healthcare landscape.

Locations

Changzhou, Jiangsu, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported